IONETIX Announces Targeted Alpha Therapy Manufacturing Center News provided by Share this article Share this article LANSING, Mich., March 16, 2021 /PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, has acquired a 10,300 sq. ft. facility in Lansing, MI for its new Targeted Alpha Radionuclide Manufacturing Center. The company is in the process of equipping the site for full cGMP drug manufacturing capabilities including a 30 MeV cyclotron unit for alpha radionuclide production to support pre-clinical research, drug development, and early stage clinical ...